Aspira Pathlab & Diagnostics Ltd - Stock Valuation and Financial Performance

BSE: 540788 | NSE: | Hospital & Healthcare Services | Small Cap

Aspira Pathlab&Diagn Share Price

31 -0.98 -3.06%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Aspira Pathlab&Diagn

M-Cap below 100cr DeciZen not available

Aspira Pathlab & Diagnostics stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
31.9 Cr.
52-wk low:
22.8
52-wk high:
49.5

Is Aspira Pathlab & Diagnostics Ltd an attractive stock to invest in?

1. Is Aspira Pathlab & Diagnostics Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Aspira Pathlab & Diagnostics Ltd is a below average quality company.

2. Is Aspira Pathlab & Diagnostics Ltd undervalued or overvalued?

The key valuation ratios of Aspira Pathlab & Diagnostics Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Aspira Pathlab & Diagnostics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Aspira Pathlab & Diagnostics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Aspira Pathlab&Diagn:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aspira Pathlab & Diagnostics Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 1.9%1.5%1.3%-26.1%-40.3%-36.9%-29%19%40.7%1.5%-
Value Creation
Index
-0.9-0.9-0.9-2.9-3.9-3.6-3.10.41.9-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0000.84.47.68.415.219.514.513
Sales YoY Gr.-NANANA473.7%75.2%10.2%80.6%28.5%-26%-
Adj EPS 0.30.10.1-5.3-10.8-6.3-4.61.34.3-0.1-2.4
YoY Gr.--66.7%33.3%-4475%NANANANA223.1%-102.1%-
BVPS (₹) 15.716.116.211.40.66.34.18.112.412.410.3
Adj Net
Profit
000-2.7-5.6-5.2-4.21.44.5-0.1-2
Cash Flow from Ops. 00-0.4-1.3-4.8-3.4-1.95.720-
Debt/CF from Ops. 00-7.2-5.7-2.4-2.2-4.20.20.4-79.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA27.1%19.8%-26%
Adj EPS -188.5%NANA-102.1%
BVPS-2.6%80.9%44.7%-0.3%
Share Price - 2.5% 2.8% 7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
1.70.90.8-57-178.6-187.6-94.322.842.3-0.7-20.8
Op. Profit
Mgn %
000-339.5-88.9-42.5-21.723.132.311-7.2
Net Profit
Mgn %
000-359.1-128.1-67.9-50.49.122.8-0.6-19
Debt to
Equity
000.71.233.91.520.20.10.1-
Working Cap
Days
0001,188353244224899117573
Cash Conv.
Cycle
0004025322917458049

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 19.75%

Return on Equity is Poor

Sales growth is not so good in last 4 quarters at -20.28%

Latest Financials - Aspira Pathlab & Diagnostics Ltd.

Standalone Consolidated
TTM EPS (₹) -2.4 -
TTM Sales (₹ Cr.) 12.8 -
BVPS (₹.) 10.3 -
Reserves (₹ Cr.) - -
P/BV 3.02 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 22.76 / 49.50
All Time Low / High (₹) 14.15 / 124.15
Market Cap (₹ Cr.) 31.9
Equity (₹ Cr.) 10.3
Face Value (₹) 10
Industry PE 83.6

Management X-Ray of Aspira Pathlab&Diagn:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Aspira Pathlab&Diagn

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales0000.764.367.648.4215.2119.5414.46
Operating Expenses 0.010.130.233.348.2310.8810.2411.6913.2312.86
Manufacturing Costs000.030.200.650.840.832.481.781.08
Material Costs0000.141.302.261.992.633.142.50
Employee Cost 0.0100.081.613.424.474.954.035.025.59
Other Costs 0.010.120.131.382.853.312.482.553.293.70
Operating Profit -0.01-0.13-0.23-2.58-3.87-3.25-1.833.516.321.59
Operating Profit Margin (%) ----339.0%-88.9%-42.5%-21.7%23.1%32.3%11.0%
Other Income 0.040.210.320.310.220.250.290.200.150.32
Interest 00.020.050.260.800.961.010.890.370.42
Depreciation 0000.201.121.231.661.441.641.59
Exceptional Items 0000000000
Profit Before Tax 0.020.070.04-2.72-5.58-5.18-4.211.384.46-0.09
Tax 0.010.040.010000.03000
Profit After Tax 0.020.020.03-2.72-5.58-5.18-4.241.384.46-0.09
PAT Margin (%) ----359.0%-128.0%-67.9%-50.4%9.1%22.8%-0.6%
Adjusted EPS (₹)0.40.10.1-5.3-10.8-6.3-4.61.34.3-0.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 0.633.613.645.920.335.193.808.3112.7912.75
Share Capital 0.402.252.255.195.198.199.2910.2910.2910.29
Reserves 0.231.361.390.72-4.86-3-5.49-1.982.502.46
Minority Interest0000000000
Debt002.626.7910.596.756.870.770.860.96
Long Term Debt0003.1710.504.784.550.770.860.96
Short Term Debt002.623.610.091.962.32000
Trade Payables0000.290.230.290.400.660.610.35
Others Liabilities 00.210.031.871.382.573.262.033.883.28
Total Liabilities 0.633.826.3014.8612.5314.8014.3411.7818.1417.34

Fixed Assets

Gross Block000.047.999.2311.4512.9113.4116.8716.88
Accumulated Depreciation0000.201.332.554.215.667.298.88
Net Fixed Assets000.047.797.918.908.707.759.578.01
CWIP 0000.25000000
Investments 0000000000
Inventories0000.120.370.280.280.370.400.40
Trade Receivables00.150.060.090.350.800.601.704.492.34
Cash Equivalents 0.033.085.332.810.220.101.101.191.642.35
Others Assets0.600.590.873.813.684.733.660.772.024.25
Total Assets 0.633.826.3014.8612.5314.8014.3411.7818.1417.34

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -0.030-0.37-1.29-4.81-3.39-1.875.672.03-0.01
PBT 0.020.070.04-2.72-5.58-5.18-4.211.384.46-0.09
Adjustment -0.04-0.03-0.020.151.711.992.402.362.401.80
Changes in Working Capital 0-0.01-0.331.29-0.94-0.19-0.031.93-4.83-1.73
Tax Paid -0.01-0.02-0.05000-0.03000
Cash Flow From Investing Activity -0.100.08-0.02-10.14-0.77-1.970.24-0.09-0.510.16
Capex 00-0.04-8.20-1-0.51-0.05-0.30-0.61-0.13
Net Investments 0.010.010-2.250-1.710000
Others -0.110.080.020.310.220.250.290.200.090.29
Cash Flow From Financing Activity 02.962.648.916.523.351.27-2.17-1.35-0.94
Net Proceeds from Shares 02.960505.102.86300
Net Proceeds from Borrowing 002.623.177.33-6.29-0.23-3.780.090.10
Interest Paid 000-0.26-0.80-0.96-1.01-0.89-0.37-0.42
Dividend Paid 0000000000
Others 000.010.9905.50-0.34-0.50-1.07-0.62
Net Cash Flow -0.133.052.25-2.520.94-2-0.353.410.17-0.79
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)2.551.10.76-57.04-178.61-187.57-94.3222.842.26-0.69
ROCE (%)3.883.951.78-25.35-38.38-34.5-26.321.5241.632.4
Asset Turnover Ratio0000.070.320.560.581.161.310.81
PAT to CFO Conversion(x)-1.50-12.33N/AN/AN/AN/A4.110.46N/A
Working Capital Days
Receivable Days00035192830285886
Inventory Days000572016128710
Payable Days000736724263747470

Aspira Pathlab & Diagnostics Ltd Stock News

Aspira Pathlab & Diagnostics Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Aspira Pathlab&Diagn on 28-Mar-2024 16:01 is ₹31.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Aspira Pathlab&Diagn stood at ₹31.91.
The latest P/E ratio of Aspira Pathlab&Diagn as of 28-Mar-2024 16:01 is 0.00.
The latest P/B ratio of Aspira Pathlab&Diagn as of 28-Mar-2024 16:01 is 3.02.
The 52-week high of Aspira Pathlab&Diagn is ₹49.50 and the 52-week low is ₹22.76.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aspira Pathlab&Diagn is ₹12.80 ( Cr.) .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited is a public limited company incorporated and domiciled in India. The company is engaged in the business of running, owning, managing and administering Diagnostics Centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.

It has its registered office at Shraddhanand Road Opp. Ghatkopar Railway Station, Ghatkopar (West) Mumbai, Maharashtra, India.

The Board of Directors of the Company, which has been identified as being the chief operating decision maker (CODM), evaluates the Company’s performance, allocate resources based on the analysis of the various performance indicator of the Company as a single unit. 

Business area of the company

The Company is solely engaged in the business of running laboratories for carrying out Pathological investigations in various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.